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Astroglial cells are crucial for central nervous system (CNS) homeostasis. They undergo
complex morpho-functional changes during aging and in response to hormonal milieu.
Ovarian hormones positively affect different astroglia parameters, including regulation of
cell morphology and release of neurotrophic and neuroprotective factors. Thus, ovarian
hormone loss during menopause has profound impact in astroglial pathophysilogy
and has been widely associated to the process of brain aging. Humanin (HN) is a
secreted mitochondrial-encoded peptide with neuroprotective effects. It is localized in
several tissues with high metabolic rate and its expression decreases with age. In the
brain, humanin has been found in glial cells in physiological conditions. We previously
reported that surgical menopause induces hippocampal mitochondrial dysfunction that
mimics an aging phenotype. However, the effect of ovarian hormone deprivation on
humanin expression in this area has not been studied. Also, whether astrocytes express
and release humanin and the regulation of such processes by ovarian hormones
remain elusive. Although humanin has also proven to be beneficial in ameliorating
cognitive impairment induced by different insults, its putative actions on structural
synaptic plasticity have not been fully addressed. In a model of surgical menopause
in rats, we studied hippocampal humanin expression and localization by real-time
quantitative polymerase chain reaction (RT-qPCR) and double immunohistochemistry,
respectively. Humanin production and release and ovarian hormone regulation of
such processes were studied in cultured astrocytes by flow cytometry and ELISA,
respectively. Humanin effects on glutamate-induced structural synaptic alterations were
determined in primary cultures of hippocampal neurons by immunocytochemistry.
Abbreviations: CNS, Central nervous system; GFAP, glial fibrillary acidic protein; HN, humanin; HNr, rattin; AD,
Alzheimer’s disease; ORF, open reading frame; rRNA, ribosomal RNA; NMDA, N-methyl-D-aspartate; CNTFR-α, ciliary
neurotrophic factor α; DMEM, Dulbecco’s Modified Eagle Medium; FCS, fetal calf serum; OVX, ovariectomized;
HPRT, hypoxanthine-guanine phosphoribosyltransferase; FITC, fluorescein isothiocyanate; DAPI, 4′,6 diamidino-2-
phenilindoledihydrocloride; E, 17β-estradiol; P, progesterone; MTT, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide; DIV, day in vitro; GH, growth hormone; IGF-1, insulin-like growth factor-1; TFAM, mitochondrial transcription
factor A; mtDNA, mitochondrial DNA; DG, dentate gyrus; GABA, γ-aminobutyric acid.
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Humanin expression was lower in the hippocampus of ovariectomized rats and its
immunoreactivity colocalized with astroglial markers. Chronic ovariectomy also promoted
the presence of less complex astrocytes in this area. Ovarian hormones increased
humanin intracellular content and release by cultured astrocytes. Humanin prevented
glutamate-induced dendritic atrophy and reduction in puncta number and total puncta
area for pre-synaptic marker synaptophysin in cultured hippocampal neurons. In
conclusion, astroglial functional and morphological alterations induced by chronic
ovariectomy resemble an aging phenotype and could affect astroglial support to neuronal
function by altering synaptic connectivity and functionality. Reduced astroglial-derived
humanin may represent an underlying mechanism for synaptic dysfunction and cognitive
decline after menopause.
Keywords: astrocytes, ovarian hormones, mitochondria, humanin, synapse, hippocampus
INTRODUCTION
Proper functioning of the central nervous system (CNS) requires
the tight intercommunication between two main cell types:
neurons and glial cells. It is now well accepted that glia functions
go much beyond mere structural and metabolic support to
neurons, indeed they are now recognized as key players in
diverse physiological processes such as synaptic communication
and plasticity, homeostasis and network-level activity in the
adult brain (Allen and Lyons, 2018). Neuron-glia interplay
is highly dynamic and prone to changes as a result of the
natural process of aging as well as alterations associated to
different pathologies (Verkhratsky et al., 2014). During aging,
both structural and physiological changes that occur in the brain
have been attributed to changes in glial cells, which reduce
their number and modify gene expression (Palmer and Ousman,
2018). In fact, glial rather than neuronal-specific genes have
been proposed to be better predictors of age (Soreq et al.,
2017). Among glial cells, astrocytes are crucial for maintaining
synaptic connectivity throughout life by means of creating a
perisynaptic sheath that accumulates molecules responsible for
synaptic support (Verkhratsky et al., 2015). Aged astrocytes
undergo profound morpho-functional alterations, which involve
retraction of their cytoplasmic processes and a decline in the
production of metabolic and trophic factors. These alterations
have a direct impact in CNS health, as aged astrocytes reduce
their neuroprotective and homeostatic capacity, altering, in turn,
neuronal synaptic connectivity and functionality (Verkhratsky
et al., 2010, 2014; Palmer and Ousman, 2018).
Ovarian hormones estradiol and progesterone have trophic
effects involved in the maintenance of both reproductive and
non-reproductive functions in different tissues (Nilsen and
Brinton, 2002; Morrison et al., 2006). In the brain, they exert
potent antioxidant and neuroprotective actions that promote
cognitive health. In fact, their loss during aging and natural or
induced menopause has been linked to several pathological
conditions, such as neuroinflammation, mitochondrial
dysfunction, synaptic decline, cognitive impairment and
increased risk of neurodegenerative disorders (Zárate et al.,
2017b). It has been reported that the density of dendritic
spines as well as synapse number in the CA1 area of the
hippocampus decrease with natural or surgical loss of ovarian
hormones (Gould et al., 1990; Woolley and McEwen, 1992,
1993; Adams et al., 2001). Many of the beneficial effects of
these hormones are mediated through their direct actions on
neurons. However, astrocytes are also cellular targets of ovarian
hormones and thus are highly involved in the protective and
reparative actions of estradiol and progesterone (Acaz-Fonseca
et al., 2014). Through binding to sex hormone receptors in
astrocytes, ovarian hormones regulate several cellular, molecular
and functional parameters in these cells, including the growth of
astroglial cytoplasmic processes, the expression of glial fibrillary
acidic protein (GFAP), glutamate transport and the release
of neurotrophic and neuroprotective factors (Acaz-Fonseca
et al., 2014, 2016; Palmer and Ousman, 2018). Considering the
active role of astrocytes in regulating synaptic maintenance and
plasticity and the dependence on ovarian hormone signaling
for several of their neuroprotective functions, it is expected that
decline in sex hormones after menopause results in impaired
astroglial synaptic function.
Humanin (HN) is a cytoprotective 24 amino acid peptide
which was originally isolated from a cDNA library constructed
from nervous tissue of a patient with familial Alzheimer’s disease
(AD). Since then, it has been identified in different species
such as mice, nematodes and rats (Niikura et al., 2004). The
rat humanin homolog rattin (HNr) is a 38 amino acid peptide
encoded and translated from an open reading frame (ORF)
within the mitochondrial 16S ribosomal RNA (rRNA) gene
(Caricasole et al., 2002; Paharkova et al., 2015). Several studies
have demonstrated that HN is a potent pro-survival factor for
neurons exposed to multiple cell stressors, such as Aβ oligomers
and over-expression of familial AD-related genes (Hashimoto
et al., 2001; Caricasole et al., 2002), serum deprivation (Kariya
et al., 2002), stroke (Xu et al., 2006; Gao et al., 2017) and
N-methyl-D-aspartate (NMDA)-induced excitotoxicity (Cui
et al., 2014). HN and its derivatives have also proven to be
beneficial in ameliorating cognitive impairment induced by Aβ,
muscarinic receptor antagonists and aging in rodents (Mamiya
and Ukai, 2001; Krejcova et al., 2004; Tajima et al., 2005;
Niikura et al., 2011; Zhang et al., 2012; Yen et al., 2018).
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Moreover, HN and HNr were reported to prevent Aβ-induced
spatial learning and memory impairments in rats by a
mechanism involving changes in long-term potentiation
(Chai et al., 2014; Wang et al., 2014), synaptic protein
expression, dendritic branch number and spine density in
the hippocampus (Chai et al., 2014).
It has been reported that HN exerts its neuroprotective
action from the extracellular space through binding to a trimeric
IL-6-receptor-related receptor(s) on the cell surface involving the
receptor for ciliary neurotrophic factor α (CNTFR-α), WSX-1
and glycoprotein 130 kDa (gp130) subunits (Matsuoka and
Hashimoto, 2010) and further modulation of tyrosin kinase,
ERK1/2, AkT, STAT3 and JNK signaling cascades (Hashimoto
et al., 2005; Matsuoka and Hashimoto, 2010; Takeshita et al.,
2013; Kim et al., 2016). HN has been ubiquitously detected
in different adult tissues with high metabolic rate, including
skeletal and cardiac muscle, cerebral cortex, hippocampus and
liver both in humans and in rodents (Caricasole et al., 2002;
Kariya et al., 2005; Muzumdar et al., 2009). The mechanisms
regulating HN expression are not fully elucidated. It has been
shown that HN levels decrease with age in human and mice
plasma as well as in the rat hypothalamus (Muzumdar et al., 2009;
Bachar et al., 2010). Also, there is a sexual dimorphism in the
expression of HN in rat anterior pituitary cells, suggesting that
sex hormones are involved in the regulation of HN biosynthesis
in this gland (Gottardo et al., 2014). In the brain, HN has been
widely localized both in neurons and glial cells, albeit the former
only in pathological conditions (Tajima et al., 2002). Thus, glial
cells have been suggested to be the main production sites of this
peptide in the brain in physiological conditions (Niikura et al.,
2004). However, astroglial HN expression and release and the
regulation of such processes by ovarian hormones have not been
studied so far.
All things considered, the aim of this work was to evaluate the
expression of HNr in the hippocampus of a rat model of surgical-
induced menopause. We also aimed at determining whether
astroglia is able to produce and release HNr in vitro and ovarian
hormone dependence on these processes. HN putative actions
on structural synaptic plasticity in a model of glutamate-induced
dendritic atrophy were also studied.
MATERIALS AND METHODS
Drugs
All drugs and reagents were obtained from Sigma Chemical
Co., St. Louis, MO, USA except for Dulbecco’s Modified
Eagle Medium (DMEM) and supplements (Gibco, Invitrogen
Carlsbad, CA, USA) fetal calf serum (FCS; Natocor, Córdoba,
Argentina) and the materials indicated below.
Animals
Adult female Wistar rats were housed in groups of four in
controlled conditions of light (12 h light-dark cycles) and
temperature (20–22◦C). Rats were fed standard lab chow and
water ad libitum and kept in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. Animal protocols were previously approved by the
Ethics Committee of the School of Medicine, University of
Buenos Aires (Res. No. 2249).
For in vivo experiments, rats were ovariectomized (OVX)
or sham-operated (SHAM) at 3 months of age under ketamine
(100 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) anesthesia and
ketoprofen (5 mg/kg) for analgesia. Beginning on week 10 post-
surgery, rat hormonal status was monitored daily by vaginal
smears. SHAM animals had 4–5 days estrous cycles while OVX
animals presented continuous diestrus status. Eleven weeks after
the surgery, rats were subjected to behavioral tests as described
below. Twelve weeks after the surgery, rats were either deeply
anesthetized (100 mg/kg ketamine and 6 mg/kg xylazine, i.p.),
transcardially perfused with heparinized saline solution and
fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (for
free-floating immunostaining of brain sections) or euthanized
in a CO2 chamber followed by decapitation (for real-time
quantitative polymerase chain reaction (RT-qPCR) assays).
Behavioral Tests
Open Field Test
The open field test was performed to evaluate animal general
locomotor activity and exploratory behavior (Gould et al., 2009).
The arena consisted of a squared open field (60× 60 cm) limited
by a 40 cm-height wall with a grided floor divided into squares
(15 × 15 cm) by lines. Animals were individually placed in
the center of the open field arena and were allowed to freely
explore for 10 min. The frequency with which the animal crossed
grid lines with all four paws (crossings) was recorded as a
measure of locomotor activity. After each animal was tested, the
open field was cleaned with a 10% ethanol-damp cloth. Testing
was performed between 10:00 and 14:00 h in a quiet room
illuminated with a 75W electric bulb, hung 75 cm above the open
field apparatus.
Y-Maze Spontaneous Alternation Test
Spontaneous alternation behavior in a Y-maze was recorded
to evaluate animal spatial working memory (Miedel et al.,
2017). The apparatus consisted of three identical black arms
(50 × 10 × 40 cm, length × width × height). Animals were
habituated to the testing room for at least 30 min prior to the test.
At the beginning of the session, animals were placed individually
at the end of one same arm of the Y-maze and allowed to freely
explore for 6 min. The whole session was recorded using a SONY
CCD-TRV75 video camera recorder connected to a personal
computer with AVerTV A833 video capture. The number of
total arm entries and the number of triads (referred as entries
to a different arm of the maze in each of three consecutive
arm entries) were recorded and the percentage of alternation
was calculated as [number of alternations/(total arm entries-
2)]× 100 (Miedel et al., 2017).
Elevated Plus Maze
The elevated plus maze test was carried out to evaluate animal
anxiety-like behavior (Walf and Frye, 2007). The apparatus
consisted of a plus-shaped maze containing two open arms
(50 × 10 cm, length × width) and two enclosed arms by 40 cm
high walls arranged such that the two open arms were opposite
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to each other. The apparatus was placed on four legs so that it
was elevated 50 cm off the floor. Testing was performed between
10:00 and 16:00 h in a quiet room illuminated with a dim light
hung 75 cm above the center of the maze. At the beginning of the
session, each animal was placed in the center of the maze facing
a close arm and allowed to freely explore for 5 min. The whole
session was recorded and behavior was assessed offline. The
number of times the animal entered an arm with all four paws
was recorded. The percentage of open arm entries was calculated
as [number of open arm entries/total arm entries]× 100.
Forced Swimming Test
The forced swimming test was performed to evaluate animal
depressive-like behaviors by quantifying their mobility and
immobility and associated behaviors (Overstreet, 2012). Each rat
was individually placed in a plastic cylinder (diameter, 40 cm;
height, 35 cm) containing water (23−25◦C) up to 25 cm from
the bottom for 5 min. At 5 s intervals throughout the test session,
the predominant behavior was assigned to one of the followings
categories: (1) immobility: lack of movement, except for the ones
needed to keep the head above water; (2) swimming: swimming
movement throughout the cylinder or (3) climbing: vigorous
movements of the forepaws in and out of the water, usually
directed against the walls. After each animal was tested, the water
was changed and the cylinder rinsed with clean water. Following
the session, each animal was dried and placed to its housing cage
in a temperature-controlled room. All swimming sessions were
carried out between 10:00 and 16:00 h.
RNA Isolation and Reverse-Transcription
Real-Time Quantitative Polymerase Chain
Reaction (RT-qPCR)
Immediately after decapitation, hippocampi from SHAM and
OVX rats were dissected on ice, snap-frozen and kept at
−80◦C until use. Total RNA was extracted from frozen
tissue using QuickZol reagent (Kalium Technologies, Buenos
Aires, Argentina) according to the manufacturer’s protocol.
One µg of total RNA was treated with 2 U DNAse (Promega
Corp., Madison, WI, USA) and then reverse transcribed
using SuperScript II Reverse Transcriptase (Invitrogen, Thermo
Fisher Scientific) following the manufacturer’s instructions.
Amplification of the products from RT reactions was performed
in duplicate using specific primers (HNr forward 5′-GAG GGT
TCA ACT GTC TCT TAC TTT CA-3′, reverse 5′-GTG AAG
AGG CTG GAA TCT CCC-3′; HPRT forward 5′-CTC ATG
GAC TGA TTA TGG ACA GGA C-3′, reverse 5′-GCA GGT
CAG CAA AGA ACT TAT AGC C-3; Invitrogen, Thermo
Fisher Scientific) and SYBRGreen SelectMasterMix (Invitrogen,
Thermo Fisher Scientific) on a StepOneTM Real-Time PCR
System (Applied Biosystems, Thermo Fisher Scientific). PCR
product specificity was verified by a melting curve analysis.
Negative RT controls were performed by omitting the addition
of the reverse transcriptase enzyme in the RT reaction, while
negative template controls were performed by addition of
nuclease-free water instead of cDNA. Both primer sets were
pre-validated to check similar efficiency ∼2 and for the use
of 2−∆∆Ct method as the quantification method (Livak and
Schmittgen, 2001). Lack of statistically significant variation of
endogenous reference gene HPRT expression between SHAM
and OVX animals was determined (Supplementary Figure S1).
Gene expression was normalized to HPRT using Step-One
Software (Applied Biosystems, Thermo Fisher Scientific), and
expressed as fold-changes relative to the control group.
Free-Floating Immunostaining of Tissue
Sections
After animal intracardiac perfusion, brains were dissected,
postfixed with 4% paraformaldehyde in 0.1 M phosphate
buffer and equilibrated in 25% (w/v) sucrose in the same
buffer. The hippocampus was serially sectioned in a freezing
microtome and the free-floating coronal 30-µm-thick tissue
sections were stored at−20◦C in 25% (w/v) sucrose in phosphate
buffer until use. The sections were blocked with 10% (v/v)
normal goat serum and incubated for 48 h with primary
antibodies against HNr (1:1,500), anti-GFAP (1:500, Millipore),
NF-200 (1:1,000), OLIG2 (1:50,000, Millipore) or S100B
(1:1,000) followed by an hour incubation with Alexa 594- or
FITC-labeled secondary antibodies (Jackson ImmunoResearch).
4′,6 diamidino-2-phenilindoledihydrocloride (DAPI) was used
for DNA staining. Negative controls were incubated in the
absence of primary antibodies (Supplementary Figure S2).
Astroglial Cell Culture
Astroglial cell cultures were prepared from neonatal rat pups of
3–4 days old. Hippocampi and cortices from four to six pups
were isolated, cut into small fragments using scissors and
then cells were mechanically dispersed by extrusion through a
Pasteur pipette in Hank’s Balanced Salt Solution. After decanting
tissue, supernatant was transferred to a new tube and pelleted.
The procedure was repeated twice and finally the cells were
plated in poly-D-lysine coated bottles with high glucose DMEM
supplemented with 10% FCS, 100 µg/ml penicillin-streptomicin
(DMEM-S) and 1 µg/ml fungizone. After the first 24 h and every
3–4 days, media was replaced with fresh DMEM-S. When the
cells reached confluence (10–12 days), they were subjected to
shaking at 180 rpm for two consecutive 24 h-periods at 37◦C
to detach microglia and oligodendrocytes. The cells were then
incubated with 0.625% 5-fluorouracil for further 24 h, washed
and incubated in fresh DMEM supplemented with 10% FCS
previously treated with 0.025% dextran-0.25% charcoal (FCS-
DCC) to remove steroids for additional 48 h. Then the cells
were tripsinized and re-seeded onto 12 well plates in DMEM
FCS-DCC for 24–48 h. Cultures obtained with this procedure
showed 93± 0.04%GFAP-positive astrocytes (n = 3 independent
cultures), as reported in the literature (Villarreal et al., 2014).
Then, the cells were cultured for 4 h in DMEM FCS-DCC
containing 1 nM 17β-estradiol (E) and 1 µMprogesterone (P) or
vehicle (ethanol, 20 µl/l), washed and cultured for further 20 h in
fresh DMEM FCS-DCC.
Expression of HNr in Astroglial Cells by
Flow Cytometry
Cultured astroglial cells were harvested with 0.025% trypsin-
EDTA, washed in cold PBS, fixed with 4% paraformaldehyde
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and permeabilized with 0.1% saponin in PBS (MP Biomedicals
Inc., OH, USA) for 10 min. Then, the cells were incubated with
rabbit anti-HNr antibody (1µg/µl) in PBS-0.05% saponin for 1 h
at 37◦C followed by 40-min incubation with a FITC-conjugated
anti-rabbit secondary antibody (1:100) in the same buffer. To
determine the cut-off for HNr fluorescence, cells were incubated
with secondary antibody only. Cells were washed, resuspended
in PBS and analyzed by flow cytometry using a FACScan (Becton
Dickinson). Data were analyzed with WinMDI 98 software.
ELISA
HNr levels in supernatants from astroglial cultures were
measured by ELISA using a commercial kit HN(N) (Rat)-
EIA Kit (Phoenix Pharmaceuticals) following the manufacturer’s
instructions and normalized to 50 µg of total protein in cell
lysates from corresponding wells. Attached astrocytes were
harvested as described above. Cells were lysed in lysis buffer
containing 150 mM NaCl, 1% Igepal, 0.02% sodium azide, 0.1%
sodium dodecyl sulfate (SDS), in 50 mM Tris-HCl pH 7.4 and a
protease inhibitor cocktail (1:50). Cell lysate was collected and
clarified by centrifugation at 16,000× g for 30 min and total
protein content was determined by the Bradford protein assay
(BioRad Laboratories, CA, USA) using bovine serum albumin
as standard.
Metabolic Activity of Viable Cells
The metabolic activity of viable cells was determined by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay (Promega, Madison, WI, USA). Cells were washed
twice and incubated for 4 h in 100 µl Krebs buffer plus 50 µg
MTT reagent in PBS at 37◦C. The developed crystals were
dissolved in 100 µl 0.04 N HCl in isopropanol and the OD
was read in a microplate spectrophotometer at a wavelength
of 600 nm. The quantity of formazan product is directly
proportional to the number of living cells in culture.
Primary Neuronal Cultures and Glutamate
Treatment
Hippocampal neuronal cultures were prepared from dissected
embryonic day 18 hippocampi as previously reported (Reinés
et al., 2012; Podestá et al., 2014). Briefly, hippocampal tissue was
trypsinized and mechanically dissociated. Then, dispersed cells
were seeded on poly-D-lysine-coated glass coverslips at a density
of 2 × 104 cells/cm2 in Neurobasal medium supplemented
with 2% (v/v) B27 and 0.5 mM glutamine. On day 13 in vitro
(DIV), neurons were treated with 5 µM glutamate or vehicle
for 3 min at 37◦C, media was immediately removed and cells
were washed with Hank’s balanced salt solution. Immediately
after, neurons were incubated with Humanin peptide (HN,
0.01–1 µM; Genemed Synthesis, Inc., San Antonio, TX, USA)
in supplemented culture media for 24 h and then fixed for
immunostaining as described below.
Immunostaining of Fixed Cells
Neurons in culture (14 DIV) were fixed in 4% (w/v)
paraformaldehyde/4% (w/v) sucrose in PBS solution, pH 7.2 for
20 min at room temperature (RT) and permeabilized with
0.2% (v/v) Triton X-100 for 10 min at RT followed by
a blockade with 5% (v/v) normal goat serum for 1 h at
RT. The cells were then incubated overnight at 4◦C with
MAP-2 (1:500) or SYN (1:2,000; Chemicon, Millopre) primary
antibodies in PBS. The next day, cells were washed and
incubated for 1 h at RT with the appropriate secondary
antibodies followed by DAPI for DNA staining. Negative
controls were incubated in the absence of primary antibodies
(Supplementary Figure S3). Finally, cells were mounted
using Mowiol.
Image Acquisition and Quantification
A Zeiss Axiophot microscope (Carl Zeiss, Oberkochen,
Germany) equipped with an Olympus Q-Color 5 camera or
a Olympus IX81 microscope equipped with a CCD model
DP71 digital camera were employed in immunohistochemistry
or immunocytochemistry assays, respectively. Confocal images
were acquired using Fluoview version 3.3 software using
an Olympus FV300 confocal microscope. Immuno-positive
structures were quantified as relative immunoreactive area
(immunoreactive area/total area) as described elsewhere using
the ImageJ (NIH) software (Reinés et al., 2008; Aviles-Reyes
et al., 2010; Codagnone et al., 2015). In immunohistochemistry
assays, the total area corresponded to the hilus, granular and
molecular layers in the superior and inferior blades of the
dentate gyrus (DG) and to pyramidal and stratum lucidum
and radiatum in CA1. Briefly, microscopic images were
captured with a digital camera, transformed to an 8-bit gray
scale and an interactive threshold was determined. Then, the
area fraction covered by immunostained structures obtained
using this threshold, which remained fixed for the entire
experiment, was quantified with the particle counting tool
of the software. In immunocytochemistry assays, dendritic
tree area per neuron was calculated by subtracting the area
corresponding to the immunolabeled soma from the total
MAP-2 immunostaining. The number of synaptic puncta, total
puncta area and individual puncta area for SYN was calculated
as previously described (Podestá et al., 2014). Figures were
prepared using Adobe Photoshop 7.0 software (Adobe Systems
Inc.). Brightness and contrast were kept constant between
the experimental groups. Each immunohistochemistry assay
consisted of 5–6 hippocampal serial sections of each animal per
group. The average data obtained from the quantification of
sections from the same animal was considered n = 1. Results
of immunohistochemistry assays are expressed as mean values
(±SEM) of n = 3–5 animals per group. Each experiment
was repeated 2–4 times. Each immunocytochemistry assay
consisted of 1–3 coverslips per experimental condition. Results
of immunocytochemistry assays are expressed as mean values
(±SEM) of 20–40 neurons per experimental condition from
two to three independent cultures. The experiments were
repeated at least twice.
Statistical Analysis
Results are expressed as mean ± SEM and evaluated by
unpaired Student’s t-test or nonparametric Mann-Whitney
U test. HNr content in conditioned media determined by
ELISA was evaluated by one-way ANOVA followed by Tukey’s
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test. Dendritic tree area, total SYN puncta area, number and
individual SYN puncta area were evaluated by two-way ANOVA
followed by Tukey’s test. Differences were considered significant
if p< 0.05.
RESULTS
Behavioral Characterization of
OVX-Induced Model of Menopause
It is now accepted that ovariectomized (OVX) adult rodents
share common features with aged animals regarding brain
function, including changes in mitochondrial function, synaptic
plasticity, behavior and cognition (Zárate et al., 2017b). To
characterize our animal model of surgical menopause in adult
Wistar rats at the behavioral level, we assessed parameters
of spatial working memory, anxiety and depression, which
are known to be modulated by ovarian hormones (Diz-
Chaves et al., 2012; Kiss et al., 2012; Cao et al., 2013;
Rodríguez-Landa et al., 2017; Hampson, 2018; da Silva Moreira
et al., 2016). Twelve-week ovarian hormone-deprived rats
showed lower spontaneous alternation behavior in the Y-maze,
indicating impaired spatial working memory (Figure 1A).
They also spent less time in the open arms and more
time immobile when subjected to the elevated plus maze
and the forced swimming test, respectively. These results
show that long-term ovarian hormone deprivation increases
anxiety-like and depressive-like behaviors (Figures 1B,C).
There were no differences in spontaneous locomotion and
exploratory behavior between OVX and control groups, as
assessed in the open field test (Figure 1D), indicating that
the observed behaviors in OVX rats cannot be attributed to
altered locomotion.
HNr Expression in the Hippocampus
Circulating levels of mitochondrial-encoded HN are known to
decline with age inmice and humans and in the rat hypothalamus
(Muzumdar et al., 2009; Bachar et al., 2010). Indeed, this
peptide has been suggested to participate in the endocrine
regulation of the aging process (Lee et al., 2014). We have
previously reported that long-term ovarian hormone deprivation
induces functional and structural alterations in hippocampal
mitochondria, which resembles amitochondrial aging phenotype
(Zárate et al., 2017a). We thus evaluated HNr expression in
the hippocampus of OVX rats by RT-qPCR. Hippocampal
expression of HNr was lower in OVX rats compared to control
rats (Figure 2). In order to identify cell types expressing
this peptide, we performed immunohistochemistry for both
HNr and different brain cell markers. HNr immunostaining
FIGURE 1 | Behavioral characterization of an animal model of surgical menopause in adult rats. Adult Wistar female rats were ovariectomized (OVX) or
sham-operated (SHAM). Twelve weeks after surgery, the animals were subjected to behavioral tests as described in “Materials and Methods” section. (A) Y-maze
spontaneous alternation test: for each animal, the number of total arm entries and the number of triads in 6 min was recorded. (B) Elevated plus maze test: each
animal was allowed to freely explore for 5 min and the number of times the animal entered an arm with all four paws was recorded. (C) Forced swimming test: every
5 s, a time-sampling technique was used to score the presence of immobility, swimming or climbing behavior. (D) SHAM or OVX rats were placed individually in the
center of a field marked with a grid of 16 equal squares for 10 min. The number of times the animal crossed each line was registered. Each column represents the
mean ± SEM of (A) the percentage of alternation, (B) the percentage of open arm entries, (C) the number of counts or (D) the number of crossings per session
(n = 4–12 animals/group); ∗p < 0.05, ∗∗∗p < 0.001, Student’s t-test.
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colocalized with astroglial marker S100B and GFAP, but
not with neuronal or oligodendroglial markers NF-200 and
OLIG-2, respectively (Figures 3, 4A). Noteworthy, some
FIGURE 2 | Expression of HNr in the hippocampus. The expression of HNr
RNA was evaluated in hippocampi from SHAM and OVX rats by real-time
quantitative polymerase chain reaction (RT-qPCR). Each column represents
the mean ± SEM of the concentration of HNr RNA relative to its internal
control HPRT expressed as fold-changes relative to SHAM group (AU;
n = 3 animals/group); ∗p < 0.05, Student’s t-test.
HNr staining could be observed in the extracellular space,
suggesting the presence of secreted HNr. Further evaluation
of HNr and GFAP expression levels in different hippocampal
subregions showed that HNr relative immunoreactive area
was lower in the CA1 region of the hippocampus of
OVX rats while there was no difference between HNr
relative immunoreactive area from OVX and control rats
in the DG (Figure 4B). OVX rats also showed lower
relative immunoreactive area for GFAP in all hippocampal
subregions studied (Figure 4B). Remarkably, there was a positive
correlation for HNr and GFAP levels in both OVX and control
groups (Figure 4C).
HNr Production and Release by Astroglia
Glial cells have been proposed as the main site of HNr
production in the brain in physiological conditions (Tajima et al.,
2002). Indeed, our results show that HNr immunoreactivity
colocalizes with astroglial markers and that OVX rats display
lower expression of HNr in the hippocampus. However, the
production and release of this peptide by astroglial cells as
well as the regulation of these processes by ovarian hormones
remain to be determined. To address this issue, cultured
astrocytes were incubated with ovarian hormones 17β-estradiol
(E) and progesterone (P) alone or in combination and released
FIGURE 3 | Double immunostaining for HNr and astroglial, neuronal or oligodendroglial markers. Coronal sections from the hippocampus of SHAM and OVX
animals were processed for double immunohistochemistry for HNr and (A) astroglial (S100B), (B) neuronal (NF-200) or (C) oligodendroglial (OLIG-2) markers.
Representative confocal microphotographs from CA1 stratum oriens (600×) show the expression of HNr (red), S100B, NF-200 or OLIG2 (green) and the merged
image (yellow). PYR, pyramidal layer; CC, corpus callosum. Scale bar = 50 µm.
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FIGURE 4 | Effects of long-term ovarian hormone deprivation on HNr and glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus. Coronal
sections from the hippocampus of SHAM and OVX animals were processed for double immunohistochemistry for HNr and GFAP. (A) Representative confocal
microphotographs from CA1 stratum oriens (600×) show the expression of HNr (red), GFAP (green) and the merged image (yellow). (B) Quantification of relative
immunoreactive area (immunoreactive area/total area) for HNr and GFAP using ImageJ software. Each column represents the mean ± SEM of relative
immunoreactive area (n = 3 animals/group). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, Student’s t-test. (C) HNr and GFAP expression levels expressed as relative
immunopositive area for each protein were normalized with respect to each corresponding hippocampal subregion (SHAM r = 0.74, p < 0.01; OVX r = 0.63,
p < 0.05, Pearson correlation test). PYR, pyramidal layer; CC, corpus callosum; DG, dentate gyrus. Scale bar = 50 µm.
HNr content was determined in the conditioned media of
cultured astrocytes by ELISA. There was a two-fold increase in
HNr levels in the conditioned media of astrocytes incubated
with E + P (Figure 5A). Then, intracellular astroglial HNr
levels were determined by immunocytochemistry and flow
cytometry. Ovarian hormones increased the intracellular content
of HNr per cell without changing the number of astrocytes
expressing this peptide (Figures 5B,C), indicating that ovarian
hormones increase both the expression and the release of HNr
by these cells.
HN Effect on Structural Synaptic Plasticity
in the Hippocampus
It has been extensively reported that ovariectomy decreases
the number of synapses and induces dendritic alterations
in hippocampal neurons (Gould et al., 1990; Woolley and
McEwen, 1992, 1993; Adams et al., 2001). However, HN effects
on these synaptic parameters have not been explored yet.
To this aim, cultured hippocampal neurons were subjected
to a brief exposure to a low glutamate concentration, a
condition that has previously been reported to induce dendritic
atrophy in the absence of neuronal death (Podestá et al., 2014).
Immediately after glutamate exposure, neurons were incubated
with HN in two different concentrations and cell viability
and synaptic parameters were studied 24 h later. Neither
glutamate nor HN affected cell viability, as assessed by
MTT assay (Figure 6). As expected, immunostaining for
the specific dendritic marker MAP-2 was reduced 24 h
after glutamate insult, rendering into a decreased neuronal
dendritic area. Remarkably, HN prevented glutamate-induced
dendritic atrophy in both concentrations studied (Figure 7).
Pre-synaptic marker SYN immunostaining was also altered
in glutamate-treated neurons, as previously reported (Podestá
et al., 2014). Remarkably, while glutamate decreased SYN puncta
number and total puncta area, both concentrations of HN
prevented glutamate actions over SYN synaptic profile. Neither
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FIGURE 5 | HNr production and release by astrocytes in vitro. Cultured astrocytes were incubated with estradiol (E) and progesterone (P). HNr secreted levels were
determined in conditioned media by ELISA. Harvested cells from additional cultures were immunostained for HNr and analyzed by flow cytometry. Each column
represents the mean ± SEM of (A) the concentration of HNr in conditioned media normalized to 50 µg of total protein in corresponding cell lysate, (B) the
fluorescence intensity of HNr staining (Gmean) or (C) the percentage of HNr-positive cells. The upper panels in (B,C) show representative histograms and dot plots
of HNr expression in astrocytes incubated with VEH or E + P (n = 3–4 wells per group from three independent experiments). (A) ∗p < 0.05 vs. respective control
without E; ANOVA followed by Tukey’s test, (B,C) ∗p < 0.05; Student’s t-test.
glutamate nor HN induced changes in SYN individual puncta
area (Figure 8).
FIGURE 6 | Effects of glutamate and HN on hippocampal neuronal cell
viability in vitro. Cultured embryonic neurons (DIV13) were subjected to a
3-min incubation with glutamate (5 µM) immediately followed by a 24-h
incubation with HN (0.01–1 µM). Cell viability was assessed by MTT assay.
Each column represents the mean ± SEM of five wells from one experiment
representative of three independent experiments. ns, non-significant; ANOVA.
DISCUSSION
Mitochondrial DNA has been classically described
as a maternally-inherited, small DNA encoding only
13 mitochondrial proteins involved in oxidative phosphorylation
and 24 structural RNAs required for their translation. However,
recent research has challenged this view (Capt et al., 2016;
Luo et al., 2018). In fact, several mitochondrial-derived
peptides encoded as genes-within-genes in short ORFs
dispersed throughout the mitochondrial genome have been
recently described (Capt et al., 2016; Kim et al., 2017). Among
them, humanin (HN) has received much attention due to its
neuroprotective effect against different types of stress and disease
models (Lee et al., 2013). Encoded within the 16S rRNA, HN has
been detected in several tissues and in circulation in rodents and
humans (Caricasole et al., 2002; Kariya et al., 2005; Muzumdar
et al., 2009) and its expression is age-dependent (Muzumdar
et al., 2009; Bachar et al., 2010). HN circulating levels both in
mice and humans are regulated by the growth hormone and
insulin-like growth factor-1 (GH/IGF-1) axis, a well conserved
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FIGURE 7 | Effect of HN on neuronal dendritic tree area in hippocampal neurons in vitro. Hippocampal neurons in culture (DIV 13) were briefly exposed to glutamate
(5 µM), immediately incubated with HN (0.01–1 µM) and evaluated 24 h later. (A) Representative microphotographs of hippocampal neurons in culture
immunostained for MAP-2. Microphotographs corresponding to 0.01 µM HN are shown, (B) Quantification of MAP-2 immunostaining using ImageJ software. Each
column represents the mean ± SEM of 20–40 neurons per experimental condition. ∧∧∧p < 0.01 vs. respective control without glutamate, ∗∗∗p < 0.001 vs.
respective control without HN; two-way ANOVA followed by Tukey’s test. Scale bar = 50 µm.
endocrine system that controls the process of aging. In fact, HN
has been suggested to be a mitochondrial signaling peptide that
is secreted and acts as a hormone involved in the endocrine
regulation of the aging process (Lee et al., 2014). We previously
reported that 12-week ovarian hormone deprivation, a model
of surgical menopause, induces mitochondrial dysfunction in
the rat hippocampus (Zárate et al., 2017a). These alterations
comprise slower active respiration and ATP production
rates as well as decreased membrane potential together with
changes in the lipid composition of mitochondrial membranes.
Remarkably, these functional and structural features are found
in mitochondria from aged animals (Pamplona, 2008; Gómez
and Hagen, 2012), further supporting the idea that ovarian
hormone loss promotes an accelerated aging phenotype, as
previously suggested (Yao et al., 2009). Ovarian hormones,
especially estrogens, are well-known regulators of mitochondrial
function, which is crucial in organs and tissues with high energy
demand like the CNS (Zárate et al., 2017b). Estrogen regulation
of mitochondrial metabolism, biogenesis and morphology has
been reported to occur in neuronal tissue (Garcia-Segura et al.,
1998; Nilsen and Brinton, 2003; Arnold et al., 2008; Brinton,
2008; Hara et al., 2014; Kemper et al., 2014; Klinge, 2017). Since
ovarian hormone loss has been associated to the process of aging
and estrogens are well-known regulators of mitochondrial gene
expression (Virbasius and Scarpulla, 1994; Kang et al., 2007),
we hypothesized that the levels of a mitochondrial-encoded
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FIGURE 8 | Effect of HN on SYN synaptic profile in hippocampal neurons in vitro. Hippocampal neurons in culture (DIV 13) were briefly exposed to glutamate
(5 µM), immediately incubated with HN (0.01–1 µM) and evaluated 24 h later. (A) Representative microphotographs of hippocampal neurons in culture
immunostained for SYN. Microphotographs corresponding to 0.01 µM HN are shown. Insets (3× magnification) detail SYN immunostaining pattern. (B)
Quantification of total SYN puncta area, SYN puncta number and individual SYN puncta area using ImageJ software. Each column represents the mean ± SEM of
20–40 neurons per experimental condition. ∧∧∧p < 0.01 vs. respective control without glutamate, ∗∗p < 0.01, ∗∗∗p < 0.001 vs. respective control without HN;
two-way ANOVA followed by Tukey’s test. Scale bar = 50 µm.
gene like HN would be decreased in hormone-deprived
animals. Indeed, herein we found that long-term ovariectomy
reduced the expression of HNr in the hippocampus. It is to
note that, although initially transcribed as long polycistronic
precursor transcripts (Ojala et al., 1981), the levels of individual
mitochondrial RNAs varies in different tissues and cell types
due to post-transcriptional processing mechanisms (Mercer
et al., 2011; Sanchez et al., 2015). Such mechanisms have been
shown to respond to the tissue hormonal milieu (Sanchez et al.,
2015). In fact, estrogen treatment has been shown to increase the
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amount of mitochondrial-encoded RNAs (Stirone et al., 2005;
Klinge, 2008). Moreover, 16S rRNA levels have been reported
to decrease with aging due to reduced rate of mitochondrial
RNA transcription (Calleja et al., 1993). Remarkably, female rats
express more 16S rRNA than males of the same chronological
age (Borras et al., 2003), suggesting a putative role of sex
hormones in the regulation of its expression. Considering that
HNr is encoded within the mitochondrial 16S rRNA molecule,
it can be speculated that similar post-transcriptional processing
mechanisms induced by hormonal environment can affect
HNr expression. Also, HN peptide seems to be associated with
lipids in different tissues (Tajima et al., 2002), suggesting that
alterations in tissue lipid composition induced by age or disease
may affect HN effective levels. Interestingly, hippocampal
mitochondria membranes fromOVX rats display an altered lipid
profile consisting of increased membrane peroxidability index
together with decreased cardiolipin levels (Zárate et al., 2017a),
which could also affect HN levels and/or distribution within
this tissue.
Different cells comprise the highly specialized and complex
nervous tissue. Although an early report showed the presence
of HN immunoreactivity in both normal and AD human brains
(Tajima et al., 2002), the specific cell types expressing this
peptide remained elusive. Tajima et al. (2002) showed HN
immunoreactivity to be located in round cells resembling glia
widely distributed in the brain, mainly in the hippocampus.
However, the identity of such glial cells was not investigated
then. HN immunoreactivity was also detected in some neurons
of the occipital lobe in the AD brain but not in an
age-matched normal brain (Tajima et al., 2002). By means of
double immunohistochemistry using neuronal, astroglial and
olidodendroglial markers in the hippocampus, we detected HNr
immunoreactivity to be located only in astrocytes, both in
OVX and control animals. However, co-immunostaining with
microglial markers was not studied and HNr localization in
microglial cells cannot be ruled out. Considering that microglia
are highly regulated by both estrogen and progesterone, further
studies are warranted to elucidate whether microglial cells also
express HNr in vivo.
The role of astroglial cells as supportive cells in the CNS is
well established. They are not only the major contributors to
cell homeostasis in the CNS but also play a central role in the
control of synaptic transmission through different mechanisms.
Perisynaptic astroglial membranous sheaths are known to cover
a high number of all synaptic contacts in the hippocampus, thus
finely regulating synaptic transmission by means of establishing
physical contact with synapses and also by secreting a plethora
of bioactive agents (Verkhratsky and Nedergaard, 2018). These
astroglial processes have been reported to be devoid of organelles
but may contain mitochondria, which, in light of our results,
could be the source of mitochondria-derived peptides with a
local role in the neighboring synapse. Considering the effect of
HN in the prevention of glutamate-induced structural synaptic
alterations shown herein, this peptide could be considered
as another bioactive molecule locally secreted by astroglia to
regulate synaptic plasticity in pathophysiological conditions. In
this way, our results add new evidence for astroglial role as a
major contributor to proper signal transmission in the CNS and
therefore to higher cognitive function.
In vitro assays using cultured astrocytes further confirmed
that this cell type is able to produce and release HNr and
that ovarian hormones positively regulate these processes. It
is well known that estradiol and progesterone exert their
actions on astrocytes through classical and non-classical receptor
signaling initiated at the nucleus, membrane or cytoplasm levels
(Acaz-Fonseca et al., 2016). By inducing the transcription of
nuclear-encoded mitochondrial transcription factor A (TFAM),
estrogens are able to promote transcription of mitochondrial
DNA (mtDNA) through a classical mechanism (Virbasius
and Scarpulla, 1994; Kang et al., 2007). Also, estrogen and
progesterone receptors have been localized within mitochondria,
suggesting that they might regulate mitochondrial transcription
through direct binding to hormone-response element-like
sequences in mtDNA (Demonacos et al., 1996; Chen et al.,
2004). Further studies are warranted to determine ovarian
hormone mechanism involved in HNr expression and release by
astroglial cells.
Estradiol and progesterone are well-known regulators of
astroglial cell morphology and GFAP expression. Evidence
supporting this includes changes in the surface density of
GFAP-immunoreactive cells in the DG of the hippocampus
along the estrous cycle (Luquin et al., 1993). Moreover,
GFAP-immunoreactive cell density in this brain area decreases
after ovariectomy and is increased by treatment with estradiol
alone or in combination with progesterone in a dose-dependent
manner (Luquin et al., 1993). It has been suggested that ovarian
hormones promote the increase in the size and/or branching of
cell processes without affecting astrocyte cell number (Tranque
et al., 1987). We evidenced the presence of qualitatively smaller,
less complex astrocytes with thinner cytoplasmic processes,
which resulted in lower GFAP relative immunoreactive area in
all subregions of the hippocampus from OVX animals. Similar
alterations in astrocyte phenotype have been described in aged
rodents, primates and humans (Castiglioni et al., 1991; Amenta
et al., 1998; Kanaan et al., 2010; Cerbai et al., 2012; Jyothi et al.,
2015; Robillard et al., 2016). For example, Cerbai et al reported
the presence of fewer, smaller and less complex GFAP-positive
astrocytes in the CA1 region of the hippocampus from 22-month
old rats (Cerbai et al., 2012). These morphological changes are
accompanied with loss of homeostatic function, which represents
an underlying mechanism for impaired neuroprotection and
disrupted neuronal connectivity (Verkhratsky et al., 2014).
Indeed, several recent reports have shown that the atrophic
astrocyte is the main astroglial phenotype not only in natural
aging but also in the early stages of neurodegenerative diseases
(Verkhratsky et al., 2014). This phenotype is characterized not
only by smaller and less complex astrocytes but also by a
decrease in glutamate uptake and glutamate synthase activity,
which may contribute to the observed general imbalance in both
excitatory and inhibitory neurotransmission as well as alterations
at the synapse level (Verkhratsky et al., 2014). It is of note that
astrocyte cytoplasmic processes form close structural contacts
with synapses to regulate all aspects of synaptic function via
the secretion of several factors (Pfrieger, 2010). Thus, it can be
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speculated that OVX may negatively impact astroglial support to
neuronal function by means of reduced synapse maintenance.
Accumulating evidence indicates that the CA1 region of the
hippocampus highly responds to natural or surgical ovarian
hormone loss by decreasing synapse number and spine density
in rats (Gould et al., 1990; Woolley and McEwen, 1992,
1993; Adams et al., 2001), which has been directly associated
to cognitive impairment. Interestingly, quantification of HN
immunoreactivity in the hippocampus of OVX rats evidenced
lower HN protein levels in the CA1 region without changes
in the DG between experimental groups, which was temporally
correlated with impaired spatial working memory. A HN
derivative has been reported to improve cognitive impairments
in different genetic mouse models of AD (Niikura et al., 2011;
Zhang et al., 2012) as well as blunt learning and memory
decline induced by Aβ peptides (Tajima et al., 2005). Also,
HN ameliorates spatial working memory deficits induced by
cholinergic antagonism- and GABA agonist-induced amnesia in
mice (Mamiya and Ukai, 2001; Krejcova et al., 2004; Tajima et al.,
2005). It has been recently reported that HN treatment improves
cognition in aged mice. Also, there is a positive correlation
between decreased HN circulating levels and accelerated
cognitive aging in humans (Yen et al., 2018). Moreover,
intrahippocampal injection of HN into the CA1 region is able
to prevent Aβ-induced memory deficits (Chai et al., 2014).
Thus, it can be hypothesized that decreased HN expression in
the CA1 region of the hippocampus could be the underlying
mechanism for cognitive impairment induced by OVX.
It is well recognized that structural synaptic plasticity, which
involves changes in synaptic architecture and number, is an
important biological basis of learning and memory (Lamprecht
and LeDoux, 2004). In vivo treatment with HN has been shown
to prevent Aβ-induced dendritic atrophy in the CA1 region of
the hippocampus by promoting dendritic branching and spine
density. These HN-induced effects occur concomitantly with an
increase in pre- and post-synaptic proteins in this hippocampal
subregion (Chai et al., 2014). To our knowledge, ours is the
first in vitro study showing that HN has a direct effect at the
synaptic level preventing glutamate-induced structural synaptic
alterations in hippocampal neurons.
HN has been shown to protect cultured rat cortical neurons
from NMDA-induced neurotoxicity, an effect that seems to be
time- and concentration-dependent (Cui et al., 2014, 2017; Yang
et al., 2018). In this study, we aimed at studying HN effects
on structural synaptic plasticity in glutamate-induced dendritic
atrophy and synapse alterations (Podestá et al., 2014). This
approach, which consists on subjecting cultured hippocampal
neurons to a brief exposure to a low glutamate concentration,
proved to be mediated by NMDA receptor (Podestá et al.,
2014). Our results show that HN is able to prevent glutamate-
induced dendritic atrophy even at the lowest concentration
studied. Interestingly, we also detected a reduction in synapse
number, evidenced by decreased SYN puncta number and
total SYN puncta area, which occurs simultaneously with
dendritic retraction. Remarkably, HN prevented these structural
synaptic alterations at concentrations that are comparable
to HNr levels detected in astrocyte conditioned media by
ELISA, suggesting that HN could be exerting its actions in
pathophysiological conditions.
In summary, our results indicate that long-term ovarian
hormone deprivation promotes structural changes in
hippocampal astrocytes, which is positively correlated with
reduced HN expression in this brain area. Our results in vitro
show that ovarian hormones positively regulate astroglial HN
expression and release and that this peptide prevents glutamate-
induced structural synaptic alterations of cultured hippocampal
neurons. Thus, OVX-induced functional and morphological
alterations in astrocytes discussed above could impair astroglial
support to neuronal function and may represent an underlying
mechanism for synaptic dysfunction after menopause. Our study
could help find new therapeutic targets for interventions that
may promote a healthier lifespan for post-menopausal women.
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FIGURE S1 | Validation of the 2−∆∆Ct method for quantitative polymerase chain
reaction (qPCR) data quantification. The efficiency of amplification of (A) the target
gene (HNr) and (B) housekeeping control (HPRT) was examined using real-time
PCR and SYBR Green detection. Using reverse transcriptase, cDNA was
synthesized from 1 µg total RNA isolated from sham-operated (SHAM) and
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ovariectomized (OVX) rat hippocampi. Serial dilutions of cDNA were amplified by
real-time PCR using gene-specific primers. The most concentrated sample
contained 200 ng of cDNA. (C) The ∆CT (CtHNr-CtHPRT) was calculated for each
cDNA dilution. The data were fit using least-squares linear regression analysis
(n = 2–3). (D) Validation of HPRT as housekeeping gene. The expression of HPRT
RNA was evaluated in hippocampi from SHAM and OVX rats by RT-qPCR. Each
column represents the mean ± SEM of the concentration of HPRT RNA
expressed as fold-changes relative to SHAM group (AU; n = 3 animals/group);
p = 0.0802, Student’s t-test.
FIGURE S2 | Negative controls for immunohistochemistry assays. Coronal
sections from the hippocampus of SHAM or OVX animals were processed for
double immunohistochemistry for HNr and GFAP. (A) Representative
microphotographs from CA1 stratum oriens show the lack of signal in the 488
(green) and 594 (red) channels in sections incubated only with secondary
antibodies (double negative control). (B) Representative microphotographs from
CA1 stratum oriens show the expression of GFAP (green) or HNr (red) together
with the lack of signal in the 594 (red) or 488 (green) channels respectively in
sections incubated in the presence of each primary antibody as indicated in the
figure and both secondary antibodies (single negative control). Nuclear staining is
shown in blue (DAPI). Scale bar = 50 µm.
FIGURE S3 | Negative controls for immunocytochemistry assays. Hippocampal
neurons in culture (DIV 13) were immunostained for double immunohistochemistry
for MAP-2 and SYN. (A) Representative microphotographs show the lack of
signal in the 488 (green) and 590 (red) channels in neurons incubated only with
secondary antibodies (double negative control). (B) Representative
microphotographs show the expression of SYN (red) or MAP-2 (green) together
with the lack of signal in the 488 (green) or 590 (red) channels respectively in
neurons incubated in the presence of each primary antibody as indicated in the
figure and both secondary antibodies (single negative control). Nuclear staining is
shown in blue (DAPI). Scale bar = 50 µm.
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